Sort
51,570 grants matching “autoimmune disease”
IEDB for Multiple sclerosis, Rheumatoid Arthritis, Lupus, and Type 1 Diabetes
$955,828Alessandro Sette · La Jolla Institute For Immunology · N01 · FY2013 · AI
Non-Invasive Treatment for Uveitis
$955,724William I Higuchi · Aciont, Inc. · R44 · FY2014 · EY
Genetics and Pathogenesis of Scleroderma
$955,026Pravitt Gourh · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2024 · AR
Hematopathology Diagnosis
$954,859Elaine Jaffe · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Metabolic gatekeepers in B-cell malignancies
$954,744Markus Mãschen · Yale University · R35 · FY2024 · CA
A Prospective Longitudinal Study of PANDAS
$954,741Yale University · R01 · FY2005 · MH
Disease Modeling Unit
$954,653Stephen A Murray · Jackson Laboratory · U54 · FY2025 · OD
Roles of non-Coding RNAs in Programming Lymphocyte Differentiation and Function
$954,267Stefan Muljo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Targeting Multiple Diseases Through Gamma Secretase
$954,099Barbara A Osborne · University Of Massachusetts Amherst · P01 · FY2010 · AG
Validation of a Negative Regulator as a Novel Therapy for Autoimmune Disease
$954,097Jay L Rothstein · Immunext, Inc. · R42 · FY2015 · AI
Project 1
$954,045Arthur Weiss · University Of California, San Francisco · P01 · FY2019 · AI
Targeting Multiple Diseases Through Gamma Secretase
$953,782Barbara A Osborne · University Of Massachusetts Amherst · P01 · FY2009 · AG
Muscle Disease Unit
$953,621Andrew Mammen · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2015 · AR
RP3: Therapeutics Human Monoclonal Antibody Treatments for Filoviruses
$953,424James E Crowe · University Of Texas Med Br Galveston · U19 · FY2017 · AI
GalNAc-specific measurement of Galactose-deficient IgA1 as a Biomarker for IgA nephropathy
$953,146Tomasz Szul · Reliant Glycosciences Llc · R44 · FY2025 · DK
Protein Sequencing by Tandem Mass Spectrometry
$953,009Donald F Hunt · University Of Virginia · R01 · FY2010 · GM
A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis
$952,967Gary Fanger · Rise Therapeutics, Llc · R44 · FY2025 · AG
AMP RA/SLE Leadership Center
$952,770Paul Joseph Utz · Stanford University · UM2 · FY2015 · AR
Aging-related Traits and Disease Risk Factors in a Sardinian Population Cohort
$952,184David Schlessinger · National Institute On Aging · ZIA · FY2017 · AG
Sjögrenâs Team for Accelerating Medicines Partnership (STAMP)
$951,759Caroline Helene Shiboski · University Of California, San Francisco · UC2 · FY2024 · DE
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
$951,710Megan Sykes · Columbia University Health Sciences · U01 · FY2022 · DK
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
$951,710Megan Sykes · Columbia University Health Sciences · U01 · FY2021 · DK
XT-101: A Novel and Potent Non-Opioid Treatment for Neuropathic Pain
$951,688Raymond A. Chavez · Xalud Therapeutics, Inc. · U44 · FY2013 · NS
Distinct contributions of CCR4 versus CCR7 to thymocyte localization and central tolerance
$951,677Lauren Ilyse Richie Ehrlich · University Of Texas At Austin · R01 · FY2021 · AI
Molecular Genetic Analysis Of Lymphocyte Function
$951,498David Margulies · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI